申请人:Cosford D. P. Nicholas
公开号:US20060193926A1
公开(公告)日:2006-08-31
Pyrrole compounds of Formula (I): and pharmaceutically acceptable salts thereof (where A, B, R
11
, R
12
, R
13
, W, X, Y and Z are as defined herein), which are substituted directly, or by a bridge, with i) a heteroaryl moiety containing N adjacent to the point of connection of the heteroaryl and ii) another heteroaryl or aryl ring, with at least one of the rings being further substituted with another ring, are mGluR5 modulators useful in the treatment of psychiatric and mood disorders such as, for example, schizophrenia, anxiety, depression, panic, and bipolar disorder, as well as in the treatment of pain, Parkinson's disease, cognitive dysfunction, epilepsy, circadian rhythm disorders, drug addiction, drug abuse, drug withdrawal, obesity and other diseases.
式(I)的吡咯化合物及其药学上可接受的盐(其中A、B、R11、R12、R13、W、X、Y和Z如本文所定义),直接或通过桥接被取代,i)含有与杂环芳基连接点相邻的N的杂环芳基基团和ii)另一个杂环芳基或芳环,其中至少一个环被进一步取代另一个环,是mGluR5调节剂,可用于治疗精神和情绪障碍,例如精神分裂症、焦虑症、抑郁症、惊恐症和双相情感障碍,以及用于治疗疼痛、帕金森病、认知功能障碍、癫痫、昼夜节律失调、药物成瘾、药物滥用、药物戒断、肥胖症和其他疾病。